5.68
price down icon4.54%   -0.27
after-market アフターアワーズ: 5.62 -0.06 -1.06%
loading

Recursion Pharmaceuticals Inc (RXRX) 最新ニュース

pulisher
01:20 AM

Recursion Pharmaceuticals (RXRX) Price Surges 9% Over Past Month - Yahoo Finance

01:20 AM
pulisher
Aug 01, 2025

Should I hold or sell Recursion Pharmaceuticals Inc. stock in 2025Daily Trading Alerts For Every Investor - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

What are the latest earnings results for Recursion Pharmaceuticals Inc.Market Forecast Alerts Backed By Experts - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

What makes Recursion Pharmaceuticals Inc. stock price move sharplyBreakout Stocks Signals Backed By Experts - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

When is Recursion Pharmaceuticals Inc. stock expected to show significant growthFinancial News Outlook For 2025 - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

What catalysts could drive Recursion Pharmaceuticals Inc. stock higher in 2025Financial News Data Feed With Proven Results - jammulinksnews.com

Aug 01, 2025
pulisher
Jul 31, 2025

What is the risk reward ratio of investing in Recursion Pharmaceuticals Inc. stockSwing Trade Growth Plan With High Returns - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

How does Recursion Pharmaceuticals Inc. generate profit in a changing economyBreakout Stocks Ideas For 2025 - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 30, 2025

Recursion Pharmaceuticals (RXRX) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance

Jul 30, 2025
pulisher
Jul 30, 2025

Drug Discovery Platforms Market Size Expected to Reach USD 635.45 Million by 2034 - GlobeNewswire Inc.

Jul 30, 2025
pulisher
Jul 29, 2025

The Median Retirement Savings for American Households Is $87,000. Here Are 3 Incredible Stocks to Buy Now and Hold for Decades. - AOL.com

Jul 29, 2025
pulisher
Jul 29, 2025

Why Recursion Pharmaceuticals (RXRX) Dipped More Than Broader Market Today - Yahoo Home

Jul 29, 2025
pulisher
Jul 29, 2025

Recursion's Q2 2025 Earnings: A TechBio Powerhouse Poised for Breakthroughs and Synergy-Driven Growth - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

Recursion to Report Second Quarter 2025 Business Updates and Financial Results on August 5th - The Globe and Mail

Jul 29, 2025
pulisher
Jul 29, 2025

Short Covering May Lift Recursion Pharmaceuticals Inc. in Near TermWeekly Growth Stock Entry Point Alerts Highlighted - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Why Recursion Pharmaceuticals Stock Got Mashed on Monday - AOL.com

Jul 28, 2025
pulisher
Jul 28, 2025

Why Recursion Pharmaceuticals (RXRX) Soared On Friday - MSN

Jul 28, 2025
pulisher
Jul 28, 2025

Recursion Pharmaceuticals Inc. Approaches Psychological Resistance LevelBreakout Entry Signal Confirmation Tool Used - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Tempus AI (TEM) vs. Recursion (RXRX): Which AI Biotech Stock Is Better? - 24/7 Wall St.

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying Recursion Pharmaceuticals Inc. stockMaximize profits with strategic stock selection - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is the dividend policy of Recursion Pharmaceuticals Inc. stockMaximize gains with timely market signals - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

How volatile is Recursion Pharmaceuticals Inc. stock compared to the marketUnlock powerful stock screening techniques - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 26, 2025

Palantir, Nvidia & Tempus AI: The Future of Medicine in 2025 - AInvest

Jul 26, 2025
pulisher
Jul 26, 2025

Big Pharma's Disruption: AI-Powered Palantir, Tempus, and Recursion Change the Game - AInvest

Jul 26, 2025
pulisher
Jul 26, 2025

Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills - Benzinga

Jul 26, 2025
pulisher
Jul 25, 2025

RXRX Stock Surges: What Awaits Next? - timothysykes.com

Jul 25, 2025
pulisher
Jul 25, 2025

Recursion Pharmaceuticals Inc. Stock Analysis and ForecastAccelerated financial growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Recursion Pharmaceuticals call volume above normal and directionally bullish - TipRanks

Jul 25, 2025
pulisher
Jul 25, 2025

How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharma - Benzinga

Jul 25, 2025
pulisher
Jul 25, 2025

RXRX vs. RLAY: Which Precision Biotech Stock is a Better Bet Now? - Yahoo Finance

Jul 25, 2025
pulisher
Jul 25, 2025

Is Recursion Pharmaceuticals Inc. a good long term investmentAccelerated capital growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

What drives Recursion Pharmaceuticals Inc. stock priceStrongest growth potential - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

How high can Recursion Pharmaceuticals Inc. stock price go in 2025Rapid return acceleration - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Recursion Pharmaceuticals (RXRX) Soars 5.8%: Is Further Upside Left in the Stock? - MSN

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Recursion Pharmaceuticals Inc. stockSignificant capital appreciation - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

RXRX September 5th Options Begin Trading - Nasdaq

Jul 24, 2025
pulisher
Jul 23, 2025

Recursion Pharmaceuticals Experiences 10.7% Stock Price Surge Amid Strong Investor Interest - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

Recursion Pharmaceuticals (RXRX) Stock Drops Despite Market Gains: Important Facts to Note - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Recursion Pharmaceuticals (RXRX) Jumps 9.6% Ahead of Q2 Earnings - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Can Recent Pipeline Expansion Efforts Offset RXRX's Earlier Losses? - The Globe and Mail

Jul 23, 2025
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
大文字化:     |  ボリューム (24 時間):